Proinflammatory and immunoregulatory roles of eicosanoids in T cells

Frontiers in Immunology

Volumn 4, Issue JUN, 2013, Pages

  Lone, Anna Mari ^a,b   Taskén, Kjetil ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

CAMP; Cyclooxygenase 2; Immunoregulation effect; Inflammation; Inflammation mediators; Leukotrienes; Prostaglandins; Regulatory T cells

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; LEUKOTRIENE; LIPOXIN; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; RECEPTOR; T LYMPHOCYTE RECEPTOR; THROMBOXANE; THROMBOXANE B2;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; BIOSYNTHESIS; CELL FUNCTION; CELLULAR IMMUNITY; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; REVIEW; T LYMPHOCYTE;

EID: 84883806336     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00130     Document Type: Review

References (182)

1. Aandahl, E. M., Moretto, W. J., Haslett, P. A., Vang, T., Bryn, T., Tasken, K., et al. (2002). Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase a type I. J. Immunol. 169, 802-808.
2. Ahmed, S. R., McGettrick, H. M., Yates, C. M., Buckley, C. D., Ratcliffe, M. J., Nash, G. B., et al. (2011). Prostaglandin D-2 regulates CD4(+) memory T cell trafficking across blood vascular endothelium and primes these cells for clearance across lymphatic endothelium. J. Immunol. 187, 1432-1439. doi:10.4049/jimmunol.1100299
3. Anastassiou, E. D., Paliogianni, F., Balow, J. P., Yamada, H., and Boumpas, D. T. (1992). Prostaglandin-E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R-alpha gene-expression at multiple levels. J. Immunol. 148, 2845-2852.
4. Austen, K. F., Maekawa, A., Kanaoka, Y., and Boyce, J. A. (2009). The leukotriene E-4 puzzle: finding the missing pieces and revealing the pathobiologic implications. J. Allergy Clin. Immunol. 124, 406-416. doi:10.1016/j.jaci.2009.05.046
5. Back, M., Dahlen, S. E., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., et al. (2011). International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions. Pharmacol. Rev. 63, 539-584. doi:10.1124/pr.110.004184
6. Bacon, K. B., Floresromo, L., Life, P. F., Taub, D. D., Premack, B. A., Arkinstall, S. J., et al. (1995). IL-8-induced signal transduction in T-lymphocytes involves receptor-mediated activation of phospholipase-C and phospholipase-D. J. Immunol. 154, 3654-3666.
7. Bacon, K. B., Schall, T. J., and Dairaghi, D. J. (1998). RANTES activation of phospholipase D in Jurkat T cells: requirement of GTP-binding proteins ARF and RhoA. J. Immunol. 160, 1894-1900.
8. Baratelli, F., Lin, Y., Zhu, L., Yang, S. C., Heuze-Vourch, N., Zeng, G., et al. (2005). Prostaglandin E-2 induces FOXP3 gene expression and T regulatory cell function in human CD4(+) T cells. J. Immunol. 175, 1483-1490.
9. Barthel, E., Rauchfuss, F., Hoyer, H., Habrecht, O., Jandt, K., Gotz, M., et al. (2012). Impact of stable PGI(2) analog iloprost on early graft viability after liver transplantation: a pilot study. Clin. Transplant. 26, E38-E47. doi:10.1111/j.1399-0012.2011.01516.x
10. Bastin, B., Payet, M. D., and Dupuis, G. (1990). Effects of modulators of adenylyl cyclase on interleukin-2 production, cytosolic Ca-2+ elevation, and K+ channel activity in Jurkat T-cells. Cell. Immunol. 128, 385-399. doi:10.1016/0008-8749(90)90035-P
11. Basu, S. (2007). Novel cyclooxygenase-catalyzed bioactive prostaglandin F-2 alpha from physiology to new principles in inflammation. Med. Res. Rev. 27, 435-468. doi:10.1002/med.20098
12. Basu, S. (2010). Bioactive eicosanoids: role of prostaglandin F-2 alpha and F-2-isoprostanes in inflammation and oxidative stress related pathology. Mol. Cells 30, 383-391. doi:10.1007/s10059-010-0157-1
13. Bergmann, C., Strauss, L., Zeidler, R., Lang, S., and Whiteside, T. L. (2007). Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Cancer Res. 67, 8865-8873. doi:10.1158/0008-5472.CAN-07-0767
14. Bertin, J., Barat, C., Methot, S., and Tremblay, M. J. (2012). Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system. Retrovirology 9, doi:10.1186/1742-4690-9-4
15. Betz, M., and Fox, B. S. (1991). Prostaglandin-E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113.
16. Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., et al. (2009). Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206, 535-548. doi:10.1084/jem.20082293
17. Boswell, M. G., Zhou, W. S., Newcomb, D. C., and Peebles, R. S. (2011). PGI(2) as a regulator of CD4+subset differentiation and function. Prostaglandins Other Lipid Mediat. 96, 21-26. doi:10.1016/j.prostaglandins.2011.08.003
18. Breyer, R. M., Bagdassarian, C. K., Myers, S. A., and Breyer, M. D. (2001). Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41, 661-690. doi:10.1146/annurev.pharmtox.41.1.661
19. Brink, C., Dahlen, S. E., Drazen, J., Evans, J. F., Hay, D. W. P., Nicosia, S., et al. (2003). International Union of Pharmacology-XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 55, 195-227. doi:10.1124/pr.55.1.8
20. Brudvik, K. W., Henjum, K., Aandahl, E. M., Bjornbeth, B. A., and Tasken, K. (2012). Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer. Cancer Immunol. Immunother. 61, 1045-1053. doi:10.1007/s00262-011-1174-4
21. Brudvik, K. W., Paulsen, J. E., Aandahl, E. M., Roald, B., and Tasken, K. (2011). Protein kinase A antagonist inhibits beta-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice. Mol. Cancer 10, doi:10.1186/1476-4598-10-149
22. Brudvik, K. W., and Tasken, K. (2012). Modulation of T cell immune functions by the prostaglandin E2-cAMP pathway in chronic inflammatory states. Br. J. Pharmacol. 166, 411-419. doi:10.1111/j.1476-5381.2011.01800.x
23. Bryn, T., Yaqub, S., Mahic, M., Henjum, K., Aandahl, E. M., and Tasken, K. (2008). LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+T cells through a COX-2-PGE(2)-dependent mechanism. Int. Immunol. 20, 235-245. doi:10.1093/intimm/dxm134
24. Burgermeister, E., Endl, J., and Scheuer, W. V. (2003). Activation of cytosolic phospholipase A(2) in human T-lymphocytes involves inhibitor-kappa B and mitogen-activated protein kinases. Eur. J. Pharmacol. 466, 169-180. doi:10.1016/S0014-2999(03)01492-4
25. Burke, J. E., and Dennis, E. A. (2009). Phospholipase A(2) biochemistry. Cardiovasc. Drugs Ther. 23, 49-59. doi:10.1007/s10557-008-6132-9
26. Carlson, C. R., Lygren, B., Berge, T., Hoshi, N., Wong, W., Tasken, K., et al. (2006). Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J. Biol. Chem. 281, 21535-21545.
27. Ceuppens, J. L., Vertessen, S., Deckmyn, H., and Vermylen, J. (1985). Effects of thromboxane-A2 on lymphocyte proliferation. Cell. Immunol. 90, 458-463. doi:10.1016/0008-8749(85)90210-2
28. Chen, H. Y., Qin, J., Wei, P., Zhang, J. G., Li, Q. X., Fu, L. H., et al. (2009). Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+T regulatory cells and Th17 cells. Prostaglandins Leukot. Essent. Fatty Acids 80, 195-200. doi:10.1016/j.plefa.2009.01.006
29. Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Lacraz, S., et al. (2008). Prostaglandin E(2) synergistically with interleukin-23 favors human Th17 expansion. Blood 112, 3696-3703. doi:10.1182/blood-2008-05-155408
30. Chouaib, S., Robb, R. J., Welte, K., and Dupont, B. (1987). Analysis of prostaglandin-E2 effect on lymphocyte-T activation-abrogation of prostaglandin-E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate. J. Clin. Invest. 80, 333-340. doi:10.1172/JCI113077
31. Chouaib, S., Welte, K., Mertelsmann, R., and Dupont, B. (1985). Prostaglandin-E2 acts at 2 distinct pathways of lymphocyte-T activation-inhibition of interleukin-2 production and down-regulation of transferrin receptor expression. J. Immunol. 135, 1172-1179.
32. Choudhry, M. A., Hockberger, P. E., and Sayeed, M. M. (1999). PGE(2) suppresses mitogen-induced Ca2+ mobilization in T cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 277, R1741-R1748.
33. Cifone, M. G., Cironi, L., Santoni, A., and Testi, R. (1995). Diacylglycerol lipase activation and 5-lipoxygenase activation and translocation following TCR/CD3 triggering in T-cells. Eur. J. Immunol. 25, 1080-1086. doi:10.1002/eji.1830250433
34. Clark, R. B., Bishop-Bailey, D., Estrada-Hernandez, T., Hla, T., Puddington, L., and Padula, S. J. (2000). The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J. Immunol. 164, 1364-1371.
35. Cook-Moreau, J. M., Hojeij, Y. E. M., Barriere, G., Rabinovitch-Chable, H. C., Faucher, K. S., Sturtz, F. G., et al. (2007). Expression of 5-lipoxygenase (5-LOX) in T lymphocytes. Immunology 122, 157-166. doi:10.1111/j.1365-2567.2007.02621.x
36. Corey, E. J., Nicolaou, K. C., Machida, Y., Malmsten, C. L., and Samuelsson, B. (1975). Synthesis and biological properties of a 9,11-azo-prostanoid-highly active biochemical mimic of prostaglandin endoperoxides. Proc. Natl. Acad. Sci. U.S.A. 72, 3355-3358. doi:10.1073/pnas.72.9.3355
37. Demeure, C. E., Yang, L. P., Desjardins, C., Raynauld, P., and Delespesse, G. (1997). Prostaglandin E-2 primes naive T cells for the production of anti-inflammatory cytokines. Eur. J. Immunol. 27, 3526-3531. doi:10.1002/eji.1830271254
38. Early, S. B., Barekzi, E., Negri, J., Hise, K., Borish, L., and Steinke, J. W. (2007). Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells. Am. J. Respir. Cell Mol. Biol. 36, 715-720. doi:10.1165/rcmb.2006-0252OC
39. Exton, J. H. (1999). Regulation of phospholipase D. Biochim. Biophys. Acta 1439, 121-133. doi:10.1016/S1388-1981(99)00089-X
40. Faith, A., Fernandez, M. H., Caulfield, J., Loke, T. K., Corrigan, C., O'Connor, B., et al. (2008). Role of cysteinyl leukotrienes in human allergen-specific Th2 responses induced by granulocyte macrophage-colony stimulating factor. Allergy 63, 168-175. doi:10.1111/j.1398-9995.2007.01531.x
41. Farrar, W. L., Evans, S. W., Rapp, U. R., and Cleveland, J. L. (1987). Effects of antiproliferative cyclic-AMP on interleukin-2-stimulated gene-expression. J. Immunol. 139, 2075-2080.
42. Feldon, S. E., O'Loughlin, C. W., Ray, D. M., Landskroner-Eiger, S., Seweryniak, K. E., and Phipps, R. P. (2006). Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am. J. Pathol. 169, 1183-1193. doi:10.2353/ajpath.2006.060434
43. Figueroa, D. J., Breyer, R. M., Defoe, S. K., Kargman, S., Daugherty, B. L., Waldburger, K., et al. (2001). Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Respir. Crit. Care Med. 163, 226-233. doi:10.1164/ajrccm.163.1.2003101
44. Folco, G., and Murphy, R. C. (2006). Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol. Rev. 58, 375-388. doi:10.1124/pr.58.3.8
45. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M. (1995). 15-deoxy-delta(12,14)-prostaglandin J(2) is a ligand for the adipocyte determination factor PPAR-gamma. Cell 83, 803-812.
46. Funk, C. D. (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875. doi:10.1126/science.294.5548.1871
47. Gelfand, E. W., and Dakhanna, A. (2006). CD8(+) T lymphocytes and leukotriene B-4: novel interactions in the persistence and progression of asthma. J. Allergy Clin. Immunol. 117, 577-582. doi:10.1016/j.jaci.2005.12.1340
48. Genaro, A. M., Sterinborda, L., Gorelik, G., and Borda, E. (1992). Prostanoid synthesis in lymphocyte subpopulations by adrenergic and cholinergic receptor stimulation. Int. J. Immunopharmacol. 14, 1145-1151. doi:10.1016/0192-0561(92)90049-Q
49. Gibbons, C. P., Wiley, K. N., Lindsey, N. J., Fox, M., Beck, S., Slater, D. N., et al. (1987). Cortical and vascular prostaglandin synthesis during renal-allograft rejection in the rat. Transplantation 43, 472-478. doi:10.1097/00007890-198704000-00003
50. Goetzl, E. J., An, S. Z., and Zeng, L. (1995). Specific suppression by prostaglandin-E(2) of activation-induced apoptosis of human CD4(+)CD8(+) T-lymphoblasts. J. Immunol. 154, 1041-1047.
51. Goodarzi, K., Goodarzi, M., Tager, A. M., Luster, A. D., and von Andrian, U. H. (2003). Leukotriene B-4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4, 965-973. doi:10.1038/ni972
52. Goodwin, J. S., Bankhurst, A. D., and Messner, R. P. (1977). Suppression of human T-cell mitogenesis by prostaglandin-existence of a prostaglandin-producing suppressor cell. J. Exp. Med. 146, 1719-1734. doi:10.1084/jem.146.6.1719
53. Greene, E. R., Huang, S., Serhan, C. N., and Panigrahy, D. (2011). Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 96, 27-36. doi:10.1016/j.prostaglandins.2011.08.004
54. Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., et al. (2009). The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30, 377-386. doi:10.1093/carcin/bgp014
55. Gualde, N., Atluru, D., and Goodwin, J. S. (1985). Effects of lipoxygenase metabolites of arachidonic-acid on proliferation of human T-cells and T-cell subsets. J. Immunol. 134, 1125-1129.
56. Harizi, H., Corcuff, J. B., and Gualde, N. (2008). Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol. Med. 14, 461-469. doi:10.1016/j.molmed.2008.08.005
57. Harris, S. G., Padilla, J., Koumas, L., Ray, D., and Phipps, R. P. (2002a). Prostaglandins as modulators of immunity. Trends Immunol. 23, 144-150. doi:10.1016/S1471-4906(01)02154-8
58. Harris, S. G., Smith, R. S., and Phipps, R. P. (2002b). 15-deoxy-Delta(12,14)-PGJ(2) induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J. Immunol. 168, 1372-1379.
59. Harris, S. G., and Phipps, R. P. (2001). The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. Eur. J. Immunol. 31, 1098-1105. doi:10.1002/1521-4141(200104)31:4<1098::AID-IMMU1098>3.0.CO;2-I
60. Harris, S. G., and Phipps, R. P. (2002). Prostaglandin D-2, its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells. Immunology 105, 23-34. doi:10.1046/j.0019-2805.2001.01340.x
61. Hendricks, A., Leibold, W., Kaever, V., and Schuberth, H. J. (2000). Prostaglandin E-2 is variably induced by bacterial super-antigens in bovine mononuclear cells and has a regulatory role for the T cell proliferative response. Immunobiology 201, 493-505. doi:10.1016/S0171-2985(00)80069-8
62. Herlong, J. L., and Scott, T. R. (2006). Positioning prostanoids of the D and J series in the immunopathogenic scheme. Immunol. Lett. 102, 121-131. doi:10.1016/j.imlet.2005.10.004
63. Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., et al. (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193, 255-261. doi:10.1084/jem.193.2.255
64. Hojo, M., Suzuki, M., Maghni, K., Hamid, Q., Powell, W. S., and Martin, J. G. (2000). Role of cysteinyl leukotrienes in CD4+ T cell-driven late allergic airway responses. J. Pharmacol. Exp. Ther. 293, 410-416.
65. Iniguez, M. A., Punzon, C., and Fresno, M. (1999). Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J. Immunol. 163, 111-119.
66. Islam, S. A., Thomas, S. Y., Hess, C., Medoff, B. D., Means, T. K., Brander, C., et al. (2006). The leukotriene B-4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood 107, 444-453. doi:10.1182/blood-2005-06-2362
67. Jaffar, Z., Wan, K. S., and Roberts, K. (2002). A key role for prostaglandin I-2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J. Immunol. 169, 5997-6004.
68. Johansson, C. C., Bryn, T., Aandahl, E. M., Areklett, M. A., Aukrust, P., Tasken, K., et al. (2004). Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy. AIDS 18, 951-952. doi:10.1097/00002030-200404090-00015
69. Joo, M., and Sadikot, R. T. (2012). PGD synthase and PGD(2) in immune response. Mediators Inflamm. 2012:503128 doi:10.1155/2012/503128
70. Kabashima, K., Murata, T., Tanaka, H., Matsuoka, T., Sakata, D., Yoshida, N., et al. (2003). Thromboxane A(2) modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4, 694-701. doi:10.1038/ni943
71. Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., et al. (2002). The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883-893. doi:10.1172/JCI14459
72. Kanaoka, Y., and Boyce, A. A. (2004). Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173, 1503-1510.
73. Kelly, J. P., Johnson, M. C., and Parker, C. W. (1979). Effect of inhibitors of arachidonic-acid metabolism on mitogenesis in human lymphocytes-possible role of thromboxanes and products of the lipoxygenase pathway. J. Immunol. 122, 1563-1571.
74. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M. (1995). A prostaglandin J(2) metabolite binds peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation. Cell 83, 813-819. doi:10.1016/0092-8674(95)90194-9
75. Kudo, I., and Murakami, M. (2002). Phospholipase A(2) enzymes. Prostaglandins Other Lipid Mediat. 68-69, 3-58. doi:10.1016/S0090-6980(02)00020-5
76. Kuehl, F. A., Humes, J. L., Egan, R. W., Ham, E. A., Beveridge, G. C., and Vanarman, C. G. (1977). Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature 265, 170-173. doi:10.1038/265170a0
77. Kvale, D., Ormaasen, V., Kran, A. M. B., Johansson, C. C., Aukrust, P., Aandahl, E. M., et al. (2006). Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment. AIDS 20, 813-820. doi:10.1097/01.aids.0000218544.54586.f1
78. Laidlaw, T. M., and Boyce, J. A. (2012). Cysteinyl leukotriene receptors, old and new; implications for asthma. Clin. Exp. Allergy 42, 1313-1320. doi:10.1111/j.1365-2222.2012.03982.x
79. Lee, B. P. L., Juvet, S. C., and Zhang, L. (2009). Prostaglandin E2 signaling through E prostanoid receptor 2 impairs proliferative response of double negative regulatory T cells. Int. Immunopharmacol. 9, 534-539. doi:10.1016/j.intimp.2009.01.023
80. Lee, I. Y., Cho, W., Kim, J., Park, C. S., and Choe, J. (2008). Human follicular dendritic cells interact with T cells via expression and regulation of cyclooxygenases and prostaglandin E and I Synthases. J. Immunol. 180, 1390-1397.
81. Lee, I. Y., Ko, E. M., Kim, S. H., Jeoung, D. I., and Choe, J. (2005). Human follicular dendritic cells express prostacyclin synthase: a novel mechanism to control T cell numbers in the germinal center. J. Immunol. 175, 1658-1664.
82. Lerner, A., Jacobson, B., and Miller, R. A. (1988). Cyclic-AMP concentrations modulate both calcium flux and hydrolysis of phosphatidylinositol phosphates in mouse lymphocytes-T. J. Immunol. 140, 936-940.
83. Leslie, C. C. (2004). Regulation of arachidonic acid availability for eicosanoid production. Biochem. Cell Biol. 82, 1-17. doi:10.1139/o03-080
84. Li, H., Bradbury, J. A., Dackor, R. T., Edin, M. L., Graves, J. P., DeGraff, L. M., et al. (2011). Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation. Am. J. Respir. Crit. Care Med. 184, 37-49. doi:10.1164/rccm.201010-1637OC
85. Liscovitch, M., Czarny, M., Fiucci, G., and Tang, X. Q. (2000). Phospholipase D: molecular and cell biology of a novel gene family. Biochem. J. 345, 401-415. doi:10.1042/0264-6021:3450401
86. Los, M., Schenk, H., Hexel, K., Baeuerle, P. A., Droge, W., and Schulzeosthoff, K. (1995). IL-2 gene-expression and NF-kappa-B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14, 3731-3740.
87. Luster, A. D., and Tager, A. M. (2004). T-cell trafficking in asthma: lipid mediators grease the way. Nat. Rev. Immunol. 4, 711-724. doi:10.1038/nri1438
88. Maekawa, A., Balestrieri, B., Austen, K. F., and Kanaoka, Y. (2009). GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D-4. Proc. Natl. Acad. Sci. U.S.A. 106, 11685-11690. doi:10.1073/pnas.0905364106
89. Mahic, M., Yaqub, S., Johansson, C. C., Tasken, K., and Aandahl, E. M. (2006). FOXP3(+)CD4(+)CD25(+) adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E-2-dependent mechanism. J. Immunol. 177, 246-254.
90. Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Jackson, E. K., Johnson, J. T., et al. (2010). Adenosine and prostaglandin E-2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J. Biol. Chem. 285, 27571-27580. doi:10.1074/jbc.M110.127100
91. Martinet, L., Jean, C., Dietrich, G., Fournie, J. J., and Poupot, R. (2010). PGE(2) inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling. Biochem. Pharmacol. 80, 838-845. doi:10.1016/j.bcp.2010.05.002
92. Mary, D., Aussel, C., Ferrua, B., and Fehlmann, M. (1987). Regulation of interleukin-2 synthesis by cAMP in human T-cells. J. Immunol. 139, 1179-1184.
93. Mastino, A., Piacentini, M., Grelli, S., Favalli, C., Autuori, F., Tentori, L., et al. (1992). Induction of apoptosis in thymocytes by prostaglandin E2 in vivo. Dev. Immunol. 2, 263-271. doi:10.1155/1992/80863
94. Medoff, B. D., Seung, E., Wain, J. C., Means, T. K., Campanella, G. S. V., Islam, S. A., et al. (2005). BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J. Exp. Med. 202, 97-110. doi:10.1084/jem.20042481
95. Melendez, A. J., and Allen, J. M. (2002). Phospholipase D and immune receptor signalling. Semin. Immunol. 14, 49-55. doi:10.1006/smim.2001.0341
96. Merhi-Soussi, F., Dominguez, Z., Macovschi, O., Dubois, M., Savany, A., Lagarde, M., et al. (2000). Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA(2). J. Leukoc. Biol. 68, 881-889.
97. Mita, H., Hasegawa, M., Saito, H., and Akiyama, K. (2001). Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils. Clin. Exp. Allergy 31, 1714-1723. doi:10.1046/j.1365-2222.2001.01184.x
98. Morita, H., Takeda, K., Yagita, H., and Okumura, K. (1999). Immunosuppressive effect of leukotriene B-4 receptor antagonist in vitro. Biochem. Biophys. Res. Commun. 264, 321-326. doi:10.1006/bbrc.1999.1523
99. Mosenden, R., Singh, P., Cornez, I., Heglind, M., Ruppelt, A., Moutschen, M., et al. (2011). Mice with disrupted type I protein kinase A anchoring in T cells resist retrovirus-induced immunodeficiency. J. Immunol. 186, 5119-5130. doi:10.4049/jimmunol.1100003
100. Mosenden, R., and Tasken, K. (2011). Cyclic AMP-mediated immune regulation-overview of mechanisms of action in T cells. Cell. Signal. 23, 1009-1016. doi:10.1016/j.cellsig.2010.11.018
101. Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., and Yamamoto, K. (2011). Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog. Lipid Res. 50, 152-192. doi:10.1016/j.plipres.2010.12.001
102. Nakanishi, M., Menoret, A., Tanaka, T., Miyamoto, S., Montrose, D. C., Vella, A. T., et al. (2011). Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity. Cancer Prev. Res. (Phila.) 4, 1198-1208. doi:10.1158/1940-6207.CAPR-11-0188
103. Nantel, F., Fong, C., Lamontagne, S., Wright, D. H., Giaid, A., Desrosiers, M., et al. (2004). Expression of prostaglandin D synthase and the prostaglandin D-2 receptors DP and CRTH2 in human nasal mucosa. Prostaglandins Other Lipid Mediat. 73, 87-101. doi:10.1016/j.prostaglandins.2003.12.002
104. Napolitani, G., Acosta-Rodriguez, E. V., Lanzavecchia, A., and Sallusto, F. (2009). Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4(+) T cells. Eur. J. Immunol. 39, 1301-1312. doi:10.1002/eji.200838969
105. Narumiya, S. (2003). Prostanoids in immunity: roles revealed by mice deficient in their receptors. Life Sci. 74, 391-395. doi:10.1016/j.lfs.2003.09.025
106. Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R., Koller, B. H., et al. (2001). Receptors for prostaglandin E-2 that regulate cellular immune responses in the mouse. J. Clin. Invest. 108, 1229-1235. doi:10.1172/JCI200113640
107. Nencioni, A., Lauber, K., Grunebach, F., Van Parijs, L., Denzlinger, C., Wesselborg, S., et al. (2003). Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. J. Immunol. 171, 5148-5156.
108. Oberprieler, N. G., Lemeer, S., Kalland, M. E., Torgersen, K. M., Heck, A. J. R., and Tasken, K. (2010). High-resolution mapping of prostaglandin E-2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8(+)CD45RO(+) T cells. Blood 116, 2253-2265. doi:10.1182/blood-2010-01-266650
109. Olschewski, H., Rose, F., Schermuly, R., Ghofrani, H. A., Enke, B., Olschewski, A., et al. (2004). Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol. Ther. 102, 139-153. doi:10.1016/j.pharmthera.2004.01.003
110. Ott, V. L., Cambier, J. C., Kappler, J., Marrack, P., and Swanson, B. J. (2003). Mast cell-dependent migration of effector CD8(+) T cells through production of leukotriene B-4. Nat. Immunol. 4, 974-981. doi:10.1038/ni971
111. Pablos, J. L., Santiago, B., Carreira, P. E., Galindo, M., and Gomez-Reino, J. J. (1999). Cyclooxygenase-1 and-2 are expressed by human T cells. Clin. Exp. Immunol. 115, 86-90. doi:10.1046/j.1365-2249.1999.00780.x
112. Pace, E., Bruno, T. F., Berenger, B., Mody, C. H., Melis, M., Ferraro, M., et al. (2007). Elevated expression of prostaglandin receptor and increased release of prostaglandin E-2 maintain the survival of CD45RO(+) T cells in the inflamed human pleural space. Immunology 121, 427-436. doi:10.1111/j.1365-2567.2007.02593.x
113. Parmentier, C. N., Fuerst, E., McDonald, J., Bowen, H., Lee, T. H., Pease, J. E., et al. (2012). Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1. J. Allergy Clin. Immunol. 129, 1136-1142. doi:10.1016/j.jaci.2012.01.057
114. Paruchuri, S., Tashimo, H., Feng, C. L., Maekawa, A., Xing, W., Jiang, Y. F., et al. (2009). Leukotriene E-4-induced pulmonary inflammation is mediated by the P2Y(12) receptor. J. Exp. Med. 206, 2543-2555. doi:10.1084/jem.20091240
115. Pettersen, F. O., Torheim, E. A., Dahm, A. E. A., Aaberge, I. S., Lind, A., Holm, M., et al. (2011). An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved t cell-dependent vaccine responses. J. Virol. 85, 6557-6566. doi:10.1128/JVI.00073-11
116. Pettersson, A., Richter, J., and Owman, C. (2003). Flow cytometric mapping of the leukotriene B-4 receptor, BLT1, in human bone marrow and peripheral blood using specific monoclonal antibodies. Int. Immunopharmacol. 3, 1467-1475. doi:10.1016/S1567-5769(03)00145-0
117. Pettipher, R., Hansel, T. T., and Armer, R. (2007). Antagonism of the prostaglandin D-2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat. Rev. Drug Discov. 6, 313-325. doi:10.1038/nrd2266
118. Pica, F., Franzese, O., Donofrio, C., Bonmassar, E., Favalli, C., and Garaci, E. (1996). Prostaglandin E(2) induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. J. Pharmacol. Exp. Ther. 277, 1793-1800.
119. Porter, B. O., and Malek, T. R. (1999). Prostaglandin E-2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction. Eur. J. Immunol. 29, 2360-2365. doi:10.1002/(SICI)1521-4141(199907)29:07<2360::AID-IMMU2360>3.0.CO;2-A
120. Prinz, I., Gregoire, C., Mollenkopft, H., Aguado, E., Wang, Y., Malissen, M., et al. (2005). The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta and gamma delta effector T cells. J. Immunol. 175, 713-719.
121. Rahmouni, S., Aandahl, E. M., Nayjib, B., Zeddou, M., Giannini, S., Verlaet, M., et al. (2004). Cyclo-oxygenase type 2-dependent prostaglandin E-2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochem. J. 384, 469-476. doi:10.1042/BJ20031859
122. Remuzzi, G., Noris, M., Benigni, A., Imberti, O., Sayegh, M. H., and Perico, N. (1994). Thromboxane A(2) receptor blocking abrogates donor-specific unresponsiveness to renal-allografts induced by thymic recognition of major histocompatibility allopeptides. J. Exp. Med. 180, 1967-1972. doi:10.1084/jem.180.5.1967
123. Rincon, M., Tugores, A., Lopezrivas, A., Silva, A., Alonso, M., Delandazuri, M. O., et al. (1988). Prostaglandin-E2 and the increase of intracellular cAMP inhibit the expression of interleukin-2 receptors in human T-cells. Eur. J. Immunol. 18, 1791-1796. doi:10.1002/eji.1830181121
124. Rolapleszczynski, M. (1985). Differential-effects of leukotriene-B-4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions. J. Immunol. 135, 1357-1360.
125. Roshak, A. K., Capper, E. A., Stevenson, C., Eichman, C., and Marshall, L. A. (2000). Human calcium-independent phospholipase A(2) mediates lymphocyte proliferation. J. Biol. Chem. 275, 35692-35698. doi:10.1074/jbc.M002273200
126. Ruiz, P., Coffman, T. M., Klotman, P. E., and Sanfilippo, F. (1989). Association of chromic thromboxane inhibition with reduced insitu cytotoxic T-cell activity in rejecting rat renal-allografts. Transplantation 48, 660-666.
127. Ruiz, P., Rey, L., Spurney, R., Coffman, T., and Viciana, A. (1992). Thromboxane augmentation of alloreactive T cell function. Transplantation 54, 498-505. doi:10.1097/00007890-199209000-00021
128. Ruppelt, A., Mosenden, R., Groenholm, M., Aandahl, E. M., Tobin, D., Carlson, C. R., et al. (2007). Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase a type I by the A-kinase anchoring protein Ezrin. J. Immunol. 179, 5159-5168.
129. Saito, M., Tanabe, Y., Kudo, I., and Nakayama, K. (2003). Endothelium-derived prostaglandin H-2 evokes the stretch-induced contraction of rabbit pulmonary artery. Eur. J. Pharmacol. 467, 151-161. doi:10.1016/S0014-2999(03)01569-3
130. Saito, S., Tsuda, H., and Michimata, T. (2002). Prostaglandin D-2 and reproduction. Am. J. Reprod. Immunol. 47, 295-302. doi:10.1034/j.1600-0897.2002.01113.x
131. Sakata, D., Yao, C. C., and Narumiya, S. (2010a). Emerging roles of prostanoids in T cell-mediated immunity. IUBMB Life 62, 591-596. doi:10.1002/iub.356
132. Sakata, D., Yao, C. C., and Narumiya, S. (2010b). Prostaglandin E-2, an immunoactivator. J. Pharmacol. Sci. 112, 1-5. doi:10.1254/jphs.09R03CP
133. Sala, A., Folco, G., and Murphy, R. C. (2010). Transcellular biosynthesis of eicosanoids. Pharmacol. Rep. 62, 503-510.
134. Scher, J. U., and Pillinger, M. H. (2005). 15d-PGJ(2): the anti-inflammatory prostaglandin? Clin. Immunol. 114, 100-109. doi:10.1016/j.clim.2004.09.008
135. Schuligoi, R., Sedej, M., Waldhoer, M., Vukoja, A., Sturm, E. M., Lippe, I. T., et al. (2009). Prostaglandin H-2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2. J. Leukoc. Biol. 85, 136-145. doi:10.1189/jlb.0608387
136. Schuligoi, R., Sturm, E., Luschnig, P., Konya, V., Philipose, S., Sedej, M., et al. (2010). CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. Pharmacology 85, 372-382. doi:10.1159/000313836
137. Sedej, M., Schroder, R., Bell, K., Platzer, W., Vukoja, A., Kostenis, E., et al. (2012). D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells. J. Allergy Clin. Immunol. 129, 492-500. doi:10.1016/j.jaci.2011.08.015
138. Seidel, S. D., Winters, G. M., Rogers, W. J., Ziccardi, M. H., Li, V., Keser, B., et al. (2001). Activation of the Ah receptor signaling pathway by prostaglandins. J. Biochem. Mol. Toxicol. 15, 187-196. doi:10.1002/jbt.16
139. Sharma, S., Yang, S. C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., et al. (2005). Tumor cyclooxygenase-2/prostaglandin E-2-dependent promotion of FOXP3 expression and CD4(+)CD25(+) T regulatory cell activities in lung cancer. Cancer Res. 65, 5211-5220. doi:10.1158/0008-5472.CAN-05-0141
140. Simmons, D. L., Botting, R. M., and Hla, T. (2004). Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 56, 387-437. doi:10.1124/pr.56.3.3
141. Singh, R. K., Gupta, S., Dastidar, S., and Ray, A. (2010). Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 85, 336-349. doi:10.1159/000312669
142. Smith, W. L. (1989). The eicosanoids and their biochemical mechanisms of action. Biochem. J. 259, 315-324.
143. Smith, W. L., DeWitt, D. L., and Garavito, R. M. (2000). Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145-182. doi:10.1146/annurev.biochem.69.1.145
144. Smith, W. L., Urade, Y., and Jakobsson, P. J. (2011). Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem. Rev. 111, 5821-5865. doi:10.1021/cr2002992
145. Snijdewint, F. G. M., Kalinski, P., Wierenga, E. A., Bos, J. D., and Kapsenberg, M. L. (1993). Prostaglandin-E(2) differentially modulates cytokine secretion profiles of human T-helper lymphocytes. J. Immunol. 150, 5321-5329.
146. Sreeramkumar, V., Fresno, M., and Cuesta, N. (2012). Prostaglandin E-2 and T cells: friends or foes? Immunol. Cell Biol. 90, 579-586. doi:10.1038/icb.2011.75
147. Stebbins, K. J., Broadhead, A. R., Baccei, C. S., Scott, J. M., Truong, Y. P., Coate, H., et al. (2010). Pharmacological blockade of the DP2 receptor inhibits cigarette smoke-induced inflammation, mucus cell metaplasia, and epithelial hyperplasia in the mouse lung. J. Pharmacol. Exp. Ther. 332, 764-775. doi:10.1124/jpet.109.161919
148. Stokka, A. J., Mosenden, R., Ruppelt, A., Lygren, B., and Tasken, K. (2010). The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMP. Biochem. J. 425, 381-388. doi:10.1042/BJ20091136
149. Tager, A. M., Bromley, S. K., Medoff, B. D., Islam, S. A., Bercury, S. D., Friedrich, E. B., et al. (2003). Leukotriene B-4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4, 982-990. doi:10.1038/ni970
150. Takahashi, Y., Tokuoka, S., Masuda, T., Hirano, Y., Nagao, M., Tanaka, H., et al. (2002). Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137, 315-322. doi:10.1038/sj.bjp.0704872
151. Tanaka, K., Hirai, H., Takano, S., Nakamura, M., and Nagata, K. (2004). Effects of prostaglandin D-2 on helper T cell functions. Biochem. Biophys. Res. Commun. 316, 1009-1014. doi:10.1016/j.bbrc.2004.02.151
152. Tanaka, K., Ogawa, K., Sugamura, K., Nakamura, M., Takano, S., and Nagata, K. (2000). Cutting edge: differential production of prostaglandin D-2 by human helper T cell subsets. J. Immunol. 164, 2277-2280.
153. Tessier, C., Hichami, A., and Khan, N. A. (2002). Implication of three isoforms of PLA(2) in human T-cell proliferation. FEBS Lett. 520, 111-116. doi:10.1016/S0014-5793(02)02779-5
154. Thomas, D. W., Rocha, P. N., Nataraj, C., Robinson, L. A., Spurney, R. F., Koller, B. H., et al. (2003). Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. J. Immunol. 171, 6389-6395.
155. Tilley, S. L., Coffman, T. M., and Koller, B. H. (2001). Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108, 15-23. doi:10.1172/JCI13416
156. Tohda, Y., Nakahara, H., Kubo, H., Haraguchi, R., Fukuoka, M., and Nakajima, S. (1999). Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin. Exp. Allergy 29, 1532-1536. doi:10.1046/j.1365-2222.1999.00710.x
157. Torres, D., Paget, C., Fontaine, J., Mallevaey, T., Matsuoka, T., Maruyama, T., et al. (2008). Prostaglandin D(2) inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of b16 melanoma. J. Immunol. 180, 783-792.
158. Trivedi, S. G., Newson, J., Rajakariar, R., Jacques, T. S., Hannon, R., Kanaoka, Y., et al. (2006). Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc. Natl. Acad. Sci. U.S.A. 103, 5179-5184. doi:10.1073/pnas.0507175103
159. Truchetet, M. E., Allanore, Y., Montanari, E., Chizzolini, C., and Brembilla, N. C. (2012). Prostaglandin I-2 analogues enhance already exuberant Th17 cell responses in systemic sclerosis. Ann. Rheum. Dis. 71, 2044-2050. doi:10.1136/annrheumdis-2012-201400
160. Tsuda, H., Michimata, T., Sakai, M., Nagata, K., Nakamura, M., and Saito, S. (2001). A novel surface molecule of Th2-and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4(+) and CD8(+) T cells during the early stage of pregnancy. Clin. Exp. Immunol. 123, 105-111. doi:10.1046/j.1365-2249.2001.01422.x
161. Ushikubi, F., Aiba, Y. I., Nakamura, K. I., Namba, T., Hirata, M., Mazda, O., et al. (1993). Thromboxane-A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J. Exp. Med. 178, 1825-1830. doi:10.1084/jem.178.5.1825
162. Vang, T., Torgersen, K. M., Sundvold, V., Saxena, M., Levy, F. O., Skalhegg, B. S., et al. (2001). Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193, 497-507. doi:10.1084/jem.193.4.497
163. von Allmen, C. E., Schmitz, N., Bauer, M., Hinton, H. J., Kurrer, M. O., Buser, R. B., et al. (2009). Secretory phospholipase A2-IID is an effector molecule of CD4(+)CD25(+) regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 106, 11673-11678. doi:10.1073/pnas.0812569106
164. Wada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., et al. (2007). Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 282, 22254-22266. doi:10.1074/jbc.M703169200
165. Wang, M. T., Honn, K. V., and Nie, D. (2007). Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev. 26, 525-534. doi:10.1007/s10555-007-9096-5
166. Woodward, D. F., Jones, R. L., and Narumiya, S. (2011). International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol. Rev. 63, 471-538. doi:10.1124/pr.110.003517
167. Wu, C. Y., Wang, K. N., McDyer, J. F., and Seder, R. A. (1998). Prostaglandin E-2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161, 2723-2730.
168. Wu, K. K., Papp, A. C., Manner, C. E., and Hall, E. R. (1987). Interaction between lymphocytes and platelets in the synthesis of prostacyclin. J. Clin. Invest. 79, 1601-1606. doi:10.1172/JCI112995
169. Xue, L., Barrow, A., and Pettipher, R. (2009a). Interaction between prostaglandin D-2 and chemoattractant receptor-homologous molecule expressed on Th2 cells mediates cytokine production by Th2 lymphocytes in response to activated mast cells. Clin. Exp. Immunol. 156, 126-133. doi:10.1111/j.1365-2249.2008.03871.x
170. Xue, L. Z., Barrow, A., and Pettipher, R. (2009b). Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 182, 7580-7586. doi:10.4049/jimmunol.0804090
171. Xue, L. Z., Barrow, A., Fleming, V. M., Hunter, M. G., Ogg, G., Klenerman, P., et al. (2012). Leukotriene E-4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D-2. J. Immunol. 188, 694-702. doi:10.4049/jimmunol.1102474
172. Xue, L. Z., Gyles, S. L., Barrow, A., and Pettipher, R. (2007). Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D-2. Biochem. Pharmacol. 73, 843-853. doi:10.1016/j.bcp.2006.11.021
173. Yamaoka, K. A., and Kolb, J. P. (1993). Leukotriene-B(4) induces interleukin-5 generation from human T-lymphocytes. Eur. J. Immunol. 23, 2392-2398. doi:10.1002/eji.1830231003
174. Yang, X. Y., Wang, L. H., Chen, T. S., Hodge, D. R., Resau, J. H., DaSilva, L., et al. (2000). Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists-PPAR gamma co-association with transcription factor NFAT. J. Biol. Chem. 275, 4541-4544. doi:10.1074/jbc.275.7.4541
175. Yao, C. C., Sakata, D., Esaki, Y., Li, Y. X., Matsuoka, T., Kuroiwa, K., et al. (2009). Prostaglandin E-2-EP4 signaling promotes immune inflammation through T(H)1 cell differentiation and T(H)17 cell expansion. Nat. Med. 15, 633-640. doi:10.1038/nm.1968
176. Yokomizo, T. (2011). "Leukotriene B-4 receptors: novel roles in immunological regulations," in Advances in Enzyme Regulation, Vol. 51, eds L. Cocco, G. Weber, and C. E. F. Weber (Amsterdam: Elsevier Science), 59-64.
177. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., and Shimizu, T. (1997). A G-protein-coupled receptor for leukotriene B-4 that mediates chemotaxis. Nature 387, 620-624. doi:10.1038/42506
178. Yokomizo, T., Izumi, T., and Shimizu, T. (2001). Co-expression of two LTB4 receptors in human mononuclear cells. Life Sci. 68, 2207-2212. doi:10.1016/S0024-3205(01)01007-4
179. Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., and Shimizu, T. (2000). A second leukotriene B-4 receptor, BLT2: a new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192, 421-431. doi:10.1084/jem.192.3.421
180. Zeddou, M., Greimers, R., de Valensart, N., Nayjib, B., Tasken, K., Boniver, J., et al. (2005). Prostaglandin E-2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8(+) T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Biochem. Pharmacol. 70, 714-724. doi:10.1016/j.bcp.2005.05.015
181. Zhou, W. S., Blackwell, T. S., Goleniewska, K., O'Neal, J. F., FitzGerald, G. A., Lucitt, M., et al. (2007). Prostaglandin I-2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells. J. Leukoc. Biol. 81, 809-817. doi:10.1189/jlb.0606375
182. Zhou, W. S., Dowell, D. R., Huckabee, M. M., Newcomb, D. C., Boswell, M. G., Goleniewska, K., et al. (2012). Prostaglandin I-2 signaling drives Th17 differentiation and exacerbates experimental autoimmune encephalomyelitis. PLoS ONE 7:e33518. doi:10.1371/journal.pone.0033518